Literature DB >> 17904882

Electrochemotherapy for the treatment of squamous cell carcinoma in cats: a preliminary report.

Enrico P Spugnini1, Bruno Vincenzi, Gennaro Citro, Giuseppe Tonini, Ivan Dotsinsky, Nikolay Mudrov, Alfonso Baldi.   

Abstract

Squamous cell carcinomas (SCC) of the skin are commonly described in cats. Reported treatments include surgery, radiation therapy and photodynamic therapy. This preliminary study reports on the management of these lesions combining the local administration of bleomycin (plus hyaluronidase for a more uniform distribution) with permeabilizing biphasic electric pulses. Nine cats with SCC graded T(2)-T(4) were treated over a 5 year period, and each cat received two sessions of electrochemotherapy (ECT) 1 week apart. The side effects of this treatment were minimal and limited to mild erythema of the nose. Seven of the cats (77.7%) had a complete response lasting up to 3 years. ECT seems to be a safe and effective option for the treatment of feline sun-induced squamous cell carcinomas and warrants further investigation.

Entities:  

Mesh:

Year:  2007        PMID: 17904882     DOI: 10.1016/j.tvjl.2007.08.011

Source DB:  PubMed          Journal:  Vet J        ISSN: 1090-0233            Impact factor:   2.688


  9 in total

1.  Electrochemotherapy for the treatment of recurring aponeurotic fibromatosis in a dog.

Authors:  Enrico P Spugnini; Giovanni Di Tosto; Scirin Salemme; Luca Pecchia; Maurizio Fanciulli; Alfonso Baldi
Journal:  Can Vet J       Date:  2013-06       Impact factor: 1.008

2.  Bleomycin/interleukin-12 electrochemogene therapy for treating naturally occurring spontaneous neoplasms in dogs.

Authors:  S D Reed; A Fulmer; J Buckholz; B Zhang; J Cutrera; K Shiomitsu; S Li
Journal:  Cancer Gene Ther       Date:  2010-02-12       Impact factor: 5.987

Review 3.  Electroporation-Based Treatments in Small Animal Veterinary Oral and Maxillofacial Oncology.

Authors:  Ana Nemec; Nina Milevoj; Urša Lampreht Tratar; Gregor Serša; Maja Čemažar; Nataša Tozon
Journal:  Front Vet Sci       Date:  2020-09-29

4.  Multiple effects of electroporation on the adhesive behaviour of breast cancer cells and fibroblasts.

Authors:  Viktoria N Pehlivanova; Iana H Tsoneva; Rumiana D Tzoneva
Journal:  Cancer Cell Int       Date:  2012-03-22       Impact factor: 5.722

5.  Electroporation Enhances Bleomycin Efficacy in Cats with Periocular Carcinoma and Advanced Squamous Cell Carcinoma of the Head.

Authors:  E P Spugnini; M Pizzuto; M Filipponi; L Romani; B Vincenzi; F Menicagli; A Lanza; R De Girolamo; R Lomonaco; M Fanciulli; G Spriano; A Baldi
Journal:  J Vet Intern Med       Date:  2015-07-20       Impact factor: 3.333

Review 6.  Adjuvant electrochemotherapy in veterinary patients: a model for the planning of future therapies in humans.

Authors:  Enrico P Spugnini; Gennaro Citro; Alfonso Baldi
Journal:  J Exp Clin Cancer Res       Date:  2009-08-14

7.  Biphasic pulses enhance bleomycin efficacy in a spontaneous canine genital tumor model of chemoresistance: Sticker sarcoma.

Authors:  Enrico P Spugnini; Ivan Dotsinsky; Nikolay Mudrov; Gennaro Citro; Alfredo D'Avino; Alfonso Baldi
Journal:  J Exp Clin Cancer Res       Date:  2008-11-03

8.  Comparison of two different doses of bleomycin in electrochemotherapy protocols for feline cutaneous squamous cell carcinoma nonsegregated from ultraviolet light exposure.

Authors:  Andrigo B De Nardi; Carlos E Fonseca-Alves; Denner S Dos Anjos; Oscar R Sierra; Enrico P Spugnini
Journal:  Sci Rep       Date:  2020-10-27       Impact factor: 4.379

9.  A Retrospective Multicentric Study of Electrochemotherapy in the Treatment of Feline Nasal Planum Squamous Cell Carcinoma.

Authors:  Petra Simčič; Alessio Pierini; George Lubas; Ron Lowe; Valentina Granziera; Raimondo Tornago; Fabio Valentini; Giulia Alterio; Matteo Cochi; Marcelo Monte Mor Rangel; Krishna Duro de Oliveira; Jennifer Ostrand Freytag; Priscila Gil Quadros; Enrico Sponza; Francesca Gattino; Joseph A Impellizeri; Filippo Torrigiani
Journal:  Vet Sci       Date:  2021-03-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.